# Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

> **NCT00234182** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 84 (—)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Interferon alpha-2b

## Key facts

- **NCT ID:** NCT00234182
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 84 (—)
- **Last updated:** 2005-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234182, "Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00234182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*